METHODS OF TREATING PODODERMATITIS

The invention relates to direct-fed microbials for use in Enterococcus species inhibition in animals. More particularly, the invention relates to isolated Bacillus strains A12, 681, 101, 235, 177, 86, and 300, and strains having all of the identifying characteristics of these strains, for a use comp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KING, Michael R, SON, Sona, GALBRAITH, Elizabeth
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FODDER FOODS OR FOODSTUFFS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to direct-fed microbials for use in Enterococcus species inhibition in animals. More particularly, the invention relates to isolated Bacillus strains A12, 681, 101, 235, 177, 86, and 300, and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention also relates to the use of isolated Bacillus strains A12, 681, 101, 235, 177, 86, and 300, and strains having all of the identifying characteristics of these strains, to prevent or reduce or control pododermatitis (footpad disease) in an animal.